Official ESCRS | European Society of Cataract & Refractive Surgeons
London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Evaluation of epithelial integrity and success rate with various transepithelial corneal cross-linking protocols for treatment of keratoconus

Poster Details

First Author: S.Taneri GERMANY

Co Author(s):    S. Oehler   H. Dick           

Abstract Details


Corneal collagen cross-linking (CXL) has been demonstrated to stiffen the cornea and halt the progression of ectasia. The original protocol requires debridement of the central corneal epithelium to facilitate diffusion of a riboflavin solution to the stroma. Recently, transepithelial CXL has been proposed to reduce the risk of complications associated with epithelial removal. We wanted to evaluate the impact of various transepithelial riboflavin delivery protocols on the corneal epithelium in regards to pain and epithelial integrity in the early postoperative period as well as their success rate.


1 Zentrum für Refraktive Chirurgie, Augenabteilung am St. Franziskus Hospital Münster; 2 Ruhr University Bochum


Case series of 175 eyes of 111 subjects affected by progressive keratoconus that underwent transepithelial CXL using 6 different riboflavin application protocols more than 1 year ago. In the early postoperative period epithelial integrity was evaluated at the slitlamp and all patients were queried if they had experienced ocular pain of any level. Success was defined as no loss of corrected distance visual acuity (CDVA) >1 line and <1 diopter of corneal steepening at the last follow-up visit (Orbscan IIz, Technolas Bausch&Lomb, Munich, Germany).


One eye had a corneal infection associated with an epithelial defect. No other adverse event including endothelial decompensation or endothelial damage was observed in any eye, except for epithelial damages. The incidence of epithelial defects at any point in the postoperative period varied according to the treatment protocol from 0 to 63%. Likewise, the incidence of reported pain varied from 0 to 83%. Success rates at latest follow-up will be presented.


Different transepithelial crosslinking protocols have varying impacts on epithelial integrity. At present, it seems impossible to have sufficient riboflavin penetration without any epithelial disruption. A compromise between efficacy and epithelial integrity has to be found.

Financial Disclosure:


Back to Poster listing